Davis Polk advised Barclays Capital Inc. and Wells Fargo Securities, LLC as joint book-running managers and representatives of the underwriters on a public offering by Laboratory Corporation of America Holdings (LabCorp) of $400 million aggregate principal amount of 2.5% senior notes due 2018 and $300 million aggregate principal amount of 4% senior notes due 2023.
Based in Burlington, North Carolina, LabCorp is the second-largest independent clinical laboratory company in the United States performing a range of clinical tests from routine blood analyses to HIV and genomic testing and specializes in developing diagnostic technologies.
The Davis Polk team included partner John G. Crowley, associate Kavita Paw and law clerk Jennifer Ying Lan. Partner Michael Farber and associate Avinash Venkatesh provided tax advice. The environmental team included counsel Loyti Cheng and associate Michael Comstock. The intellectual property team included partner Frank J. Azzopardi and law clerk Dan Karmel. Rosemarie Melendez and Sorina Delia Lazar were the legal assistants on the transaction. All members of the Davis Polk team are based in the New York office.
